New Member to the CCRA Advisory Board
CCRA welcomes Dr. Dajan O’Donnell to its Advisory Board as the representative for the Cancer Research Society, where he serves as the Director of Scientific Affairs and Partnerships. Dajan is a seasoned professional with recent experience at Exactis Innovation and a long tenure in the pharmaceutical industry. He has a PhD in neurology and neurosurgery.
Spanning Bench to Behaviour: Webinar
This webinar, "Spanning Bench to Behaviour: Harnessing CPTP data to understand lifestyle risks across the health spectrum," will provide an overview of the types of data collected through the Canadian Partnership for Tomorrow Project (CPTP) — Canada’s largest population study of 330,000 Canadians in six regional coh... Read More »
This webinar, "Spanning Bench to Behaviour: Harnessing CPTP data to understand lifestyle risks across the health spectrum," will provide an overview of the types of data collected through the Canadian Partnership for Tomorrow Project (CPTP) — Canada’s largest population study of 330,000 Canadians in six regional coh... Read More »
2018 Investment in Cancer Research: Report Released
Today, CCRA released its latest report on the investment in cancer research. It reveals that $491M was invested in cancer research in 2018. Although a slight increase since 2017 (up $17M), the investment has been fairly constant over the past five years.
This year's report includes some new analyses, which quantify the cancer-... Read More »
Today, CCRA released its latest report on the investment in cancer research. It reveals that $491M was invested in cancer research in 2018. Although a slight increase since 2017 (up $17M), the investment has been fairly constant over the past five years.
This year's report includes some new analyses, which quantify the cancer-... Read More »